Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Biotechnology

Delix Therapeutics

Delix Therapeutics' headquarters in Boston, MA, United States

Mark Rus

Aaron Koenig MD

Eliseo Salinas

Matt Gorman

Tricia Mccall

Retsina Meyer

David Olson

Nick Haft

John Krystal

Florence Wagner

Craig Lindsley

Conor Liston

Jacob Hooker

Stephen Stahl

Michael Cola

The Advisory team at Delix Therapeutics provides strategic guidance and expert insights to support the development and regulatory approval of non-hallucinogenic psychedelic therapies. Comprised of experienced advisors, this team collaborates closely with research, clinical, and regulatory departments to ensure that the company's innovative psychoplastogen compounds meet safety, efficacy, and compliance standards.

Advisory

The Corporate Strategy team at Delix Therapeutics is responsible for driving the company's long-term vision and growth initiatives. This includes market analysis, competitive intelligence, strategic partnerships, and guiding the company's preclinical and clinical development programs. The team ensures alignment between scientific advancements and business objectives to achieve the goal of alleviating mental suffering with safe, non-hallucinogenic psychoplastogen compounds.

Corporate Strategy

The Leadership Team at Delix Therapeutics is responsible for steering the company’s strategic vision and operational execution in developing innovative, non-hallucinogenic psychedelic therapies. Comprising executives from diverse backgrounds, including scientific research, corporate governance, and human resources, the team collaborates to drive progress through preclinical and clinical stages, ensuring alignment with regulatory standards while fostering a culture of innovation and ethical responsibility in addressing mental health challenges.

Leadership Team

Delix Therapeutics

Org chart

Board & advisors

Teams

Advisory

Corporate Strategy

Leadership Team

Offices

Delix Therapeutics

Org chart

Board & advisors

Teams

Advisory

Corporate Strategy

Leadership Team

Offices

Related companies